Synthesis, molecular docking, molecular dynamics and evaluation of Drug-Likeness properties of the fused N-Formyl pyrazoline substituted new dehydroepiandrosterone derivatives

dc.contributor.authorCapan, Irfan
dc.contributor.authorShehu, Abdulmalik
dc.contributor.authorSert, Yusuf
dc.contributor.authorCelik, Ismail
dc.contributor.authorErol, Meryem
dc.contributor.authorKoca, Irfan
dc.contributor.authorServi, Suleyman
dc.date.accessioned2026-08-12T17:20:08Z
dc.date.issued2023
dc.departmentFırat Üniversitesi
dc.description.abstractThe hybrid molecules bearing heterocyclic structures in the A or D rings of steroids have significant biological activity. 16 (E)-Hetereoarylidene steroids were synthesized from the reaction of different heteroaromatic carbaldehydes and trans-Dehydroepiandrosterone (DHEA) in a basic medium. Then, synthesis of the N-formyl pyrazoline substituted new DHEA derivatives were carried out from the reaction of hydrazine hydrate and 16 (E)-hetereoarylidene steroids. The structures of the synthesized compounds were elucidated by elemental analysis, FT-IR, H-1 NMR, and C-13 NMR spectroscopy. To investigate the activation pathway of synthesized N-formyl pyrazoline substituted steroid derivatives, a molecular docking study was performed on human cytochrome P450-(CYP17A1: PDB ID 5IRQ) with the help of the free AutoDock Vina. 100 ns molecular dynamic simulation process was performed to monitor the behavior of the complex structure formed by CYP17A1 and to calculate the stability over time of 2a and 2d (-9.8 kcal/mol), which gave the lowest value according to the results obtained in the molecular docking study with AutoDock Vina. Accordingly, RMSD, RMSF, Rg, and SASA analyzes of 2a and 2d were performed, and MMPBSA was calculated. Lastly, the ADMET (absorption, distribution, metabolism, excretion, and toxicity) analyses of the novel steroid derivatives were investigated. Communicated by Ramaswamy H. Sarma
dc.description.sponsorshipFi rat University Research Project Coordination Unit [FF.17.03]
dc.description.sponsorshipWe would like to thank Fi rat University Research Project Coordination Unit (Project Number FF.17.03) for the financial support of this work.
dc.identifier.doi10.1080/07391102.2022.2034667
dc.identifier.endpage2503
dc.identifier.issn0739-1102
dc.identifier.issn1538-0254
dc.identifier.issue6
dc.identifier.orcid0000-0002-8146-1663
dc.identifier.orcid0000-0001-8836-8667
dc.identifier.orcid0000-0001-7873-159X
dc.identifier.orcid0000-0002-9555-1555
dc.identifier.pmid35132941
dc.identifier.scopus2-s2.0-85124909106
dc.identifier.scopusqualityQ1
dc.identifier.startpage2492
dc.identifier.urihttps://doi.org/10.1080/07391102.2022.2034667
dc.identifier.urihttps://hdl.handle.net/11508/53449
dc.identifier.volume41
dc.identifier.wosWOS:000753014800001
dc.identifier.wosqualityQ3
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherTaylor & Francis Inc
dc.relation.ispartofJournal of Biomolecular Structure & Dynamics
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WoS_20260511
dc.subjecttrans-Dehydroepiandrosterone
dc.subjectsteroid
dc.subjectpyrazoline
dc.subjectmolecular docking
dc.subjectmolecular dynamic
dc.subjectADMET analysis
dc.titleSynthesis, molecular docking, molecular dynamics and evaluation of Drug-Likeness properties of the fused N-Formyl pyrazoline substituted new dehydroepiandrosterone derivatives
dc.typeArticle

Dosyalar